Barclays PLC purchased a new stake in Cronos Group Inc. (NASDAQ:CRON – Free Report) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 44,345 shares of the company’s stock, valued at approximately $97,000.
Other large investors have also recently added to or reduced their stakes in the company. Mackenzie Financial Corp acquired a new stake in Cronos Group in the second quarter valued at $3,237,000. International Assets Investment Management LLC lifted its stake in Cronos Group by 119.0% in the third quarter. International Assets Investment Management LLC now owns 41,643 shares of the company’s stock valued at $91,000 after acquiring an additional 22,628 shares during the last quarter. National Bank of Canada FI lifted its stake in Cronos Group by 1,094.4% in the second quarter. National Bank of Canada FI now owns 15,169 shares of the company’s stock valued at $35,000 after acquiring an additional 13,899 shares during the last quarter. Headlands Technologies LLC lifted its stake in Cronos Group by 12,309.4% in the second quarter. Headlands Technologies LLC now owns 27,797 shares of the company’s stock valued at $65,000 after acquiring an additional 27,573 shares during the last quarter. Finally, Renaissance Technologies LLC lifted its stake in Cronos Group by 37.9% in the second quarter. Renaissance Technologies LLC now owns 464,949 shares of the company’s stock valued at $1,083,000 after acquiring an additional 127,753 shares during the last quarter. Institutional investors and hedge funds own 8.71% of the company’s stock.
Cronos Group Stock Performance
NASDAQ CRON opened at $2.03 on Thursday. The firm has a 50-day moving average of $2.04 and a 200-day moving average of $2.18. The stock has a market cap of $776.06 million, a PE ratio of -15.62 and a beta of 0.97. Cronos Group Inc. has a 52-week low of $1.86 and a 52-week high of $3.14.
Cronos Group Profile
Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
See Also
- Five stocks we like better than Cronos Group
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- 3 Warren Buffett Stocks to Buy Now
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- Which Wall Street Analysts are the Most Accurate?
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Want to see what other hedge funds are holding CRON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cronos Group Inc. (NASDAQ:CRON – Free Report).
Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.